The intent of CAD-RADS -Coronary Artery Disease Reporting and Data System is to create a standardized method to communicate findings of coronary CT angiography (coronary CTA) in order to facilitate decision-making regarding further patient management. The suggested CAD-RADS classification is applied on a per-patient basis and represents the highest-grade coronary artery lesion documented by coronary CTA. It ranges from CAD-RADS 0 (Zero) for the complete absence of stenosis and plaque to CAD-RADS 5 for the presence of at least one totally occluded coronary artery and should always be interpreted in conjunction with the impression found in the report. Specific recommendations are provided for further management of patients with stable or acute chest pain based on the CAD-RADS classification. The main goal of CAD-RADS is to standardize reporting of coronary CTA results and to facilitate communication of test results to referring physicians along with suggestions for subsequent patient management. In addition, CAD-RADS will provide a framework of standardization that may benefit education, research, peer-review and quality assurance with the potential to ultimately result in improved quality of care. (J Am Coll Cardiol Img 2016;9:1099-113)
INTRODUCTION
Coronary CT Angiography (coronary CTA) has made substantial progress since the introduction of 64-slice CT scanners approximately 10 years ago (1), both Coronary Artery Disease -Reporting and Data System S E P T E M B E R 2 0 1 6 : 1 0 9 9 -1 1 3 concerning imaging technology and clinical validation.
In parallel, several professional societies have issued guidelines, expert consensus documents, and Appropriateness Criteria for coronary CTA (2) (3) (4) (5) (6) (7) (8) . To maximize the clinical impact of coronary CTA, imaging protocols must be optimized with respect to image quality, diagnostic accuracy, and radiation dose. Training and interpretation standards are important. Finally, standardized reporting is helpful to decrease variability among practitioners and may provide further benefit by linking the final impression in the report with suggestions for further patient management.
Other fields in medical imaging (notably, breast imaging with BI-RADS) have introduced standardized reporting linked with actionable information to guide next steps in patient management (9) . BI-RADS standardized reporting of screening mammograms allows clinicians to interpret the clinical relevance of reported findings and to take action. Moreover, BI-RADS facilitates collection of data for registries and databases, allowing better tracking of individual patient outcomes with specific imaging findings.
Next to BI-RADS, standardized reporting has been introduced for several other fields. They include, for example:
LI-RADS TM (Liver Imaging Reporting and Data
System) for standardization reporting in patients with chronic liver disease (10) .
Lung-RADS TM (Lung CT Screening Reporting and
Data System) for standardization reporting of highrisk smokers undergoing CT lung screening (11) .
PI-RADS TM (Prostate Imaging Reporting and Data
System) for multi-parametric MR imaging in the context of prostate cancer (12) .
The purpose of this document is to describe a standardized reporting system for patients undergoing coronary CTA. The report system is named CAD-
RADS (Coronary Artery Disease Reporting and Data
System) and is applicable to coronary CTA in patients with suspected or known coronary artery disease either in the outpatient, inpatient or emergency department setting. It includes suggestions regarding further patient management, which, obviously will The CAD-RADS classification should be applied on a per-patient basis for the clinically most relevant (usually highest-grade) stenosis. All vessels greater than 1.5 mm in diameter should be graded for stenosis severity. CAD-RADS will not apply for smaller vessels (<1.5 mm in diameter). MODIFIERS: If more than one modifier is present, the symbol "/" (slash) should follow each modifier in the following order: First: modifier 
CAD-RADS 1
1-24%** ACS highly unlikely Consider evaluation of non-ACS etiology, if normal troponin and no ECG changes. Consider referral for outpatient follow-up for preventive therapy and risk factor modification.
CAD-RADS 2
25-49%*** ACS unlikely Consider evaluation of non-ACS etiology, if normal troponin and no ECG changes. Consider referral for outpatient follow-up for preventive therapy and risk factor modification.
If clinical suspicion of ACS is high or if high-risk plaque features are noted, consider hospital admission with cardiology consultation.
CAD-RADS 3

50-69%
ACS possible Consider hospital admission with cardiology consultation, functional testing and/or ICA**** for evaluation and management. Recommendation for anti-ischemic and preventive management should be considered as well as risk factor modification. Other treatments should be considered if presence of hemodynamically significant lesion.
CAD-RADS 4
A -70-99% or B -Left main >50% or 3-vessel obstructive disease ACS likely Consider hospital admission with cardiology consultation. Further evaluation with ICA and revascularization as appropriate. Recommendation for anti-ischemic and preventive management should be considered as well as risk factor modification.
CAD-RADS 5 100% (Total occlusion)
ACS very likely Consider expedited ICA on a timely basis and revascularization if appropriate if acute occlusion***** Recommendation for anti-ischemic and preventive management should be considered as well as risk factor modifications.
CAD-RADS N
Non-diagnostic study
ACS cannot be excluded Additional or alternative evaluation for ACS is needed
The CAD-RADS classification should be applied on a per-patient basis for the clinically most relevant (usually highest-grade) stenosis. All vessels greater than 1.5 mm in diameter should be graded for stenosis severity. CAD-RADS will not apply for smaller vessels (<1.5 mm in diameter). MODIFIERS: If more than one modifier is present, the symbol "/" (slash) should follow each modifier in the following order: ****ICA -invasive coronary angiography. *****Unless the total coronary occlusion can be identified as chronic (through CT and clinical characteristics or patient history).
Cury et al.
Coronary Artery Disease -Reporting and Data System S E P T E M B E R 2 0 1 6 : 1 0 9 9 -1 1 3 stenosis severity, a classification system suggested by the Society of Cardiovascular Computed Tomography is used (see Table 1 ). Tables 2 and 3 list the categories of the CAD-RADS reporting system for stable chest pain ( Table 2 ) and acute chest pain ( Table 3) Normal left main, LAD, LCX and RCA without plaque or stenosis.
FIGURE 2 CAD-RADS 1
Minimal calcified plaque in the proximal LAD with minimal luminal narrowing (less than 25% diameter stenosis).
Cury et al. Cury et al. Focal non-calcified plaque in the mid LAD (yellow arrow) with 70-99% diameter stenosis (left). Invasive coronary angiography confirming 70-99% stenosis in the mid LAD (yellow arrow, right).
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FIGURE 6 CAD-RADS 4B
Three-vessel obstructive disease (>70% stenosis), including in 70-99% stenosis of the proximal RCA (left), 70-99% stenosis of the proximal LAD (middle) and 70-99% stenosis of the mid LCX (right).
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Coronary Artery Disease -Reporting and Data System
(1-24%), or no more than mild stenosis (25-49%) in interpretable segments, CAD-RADS N should be used since Coronary CTA cannot be used to guide patient management and further evaluation to exclude obstructive coronary artery disease is still needed.
II. Modifier S -Presence of a stent
The 
III. Modifier G ¼ Presence of coronary bypass grafts:
The modifier "G" indicates the presence of at least one coronary-artery bypass graft (Figure 12) . A If a coronary plaque clearly demonstrates two or more high-risk features by coronary CTA, the modifier "V" (vulnerability) should be added (Figures 13 and 14) . High-risk features include: low attenuation plaque (less than 30 Hounsfield Units), positive remodeling, spotty calcification, and the "napkin ring sign" (see Figure 13 ). In-stent stenosis of the proximal LAD with significant luminal narrowing (70-99% stenosis). Grading of in-stent stenosis should follow the grading of normal coronary arteries (0% stenosis, 1-24% stenosis, 25-49% stenosis, 50-69% stenosis, 70-99% stenosis, and >99% stenosis).
In this case, severe in-stent restenosis designates a CAD-RADS 4A lesion, which would be followed by the stent modifier "S."
FIGURE 12 MODIFIER G
Coronary CTA demonstrating a patent left internal mammary artery to the LAD and patent saphenous vein grafts to the ramus intermedius and second obtuse marginal branch. No stenoses or luminal narrowing throughout the grafts (0% stenosis, left). Invasive coronary angiography demonstrating patent LIMA graft to the LAD (right). When evaluating coronary CTA of patients with bypass grafts, the native coronary artery segments proximal to the graft anastamoses should not be evaluated for purposes of CAD RADS coding. Only the grafts and the native coronary artery segments distal to and including the anastomosis should be evaluated for CAD RADS coding.
Cury et al. CAD-RADS is intended to be a "living document"
that undergoes continued development to provide upto-date, evidence based recommendations to achieve its goal of being a tool that imagers can use to communicate with clinicians and to convey concise findings using unambiguous and standardized terminology. Next to its utilization in clinical reporting, CAD-RADS will allow reliable and reproducible data Example demonstrating a patent stent in the proximal RCA (0% stenosis) with high-risk plaque in the proximal LAD resulting in 50-69% stenosis. In isolation, the proximal LAD lesion would be coded CAD RADS 3/V. However, since CAD RADS is coded on a per-patient basis, and a RCA stent is present, this patient would be coded as CAD RADS 3/S/V. The plaque demonstrates two high risk features, low attenuation (<30 HU) and positive remodeling, thus coding with the modifier "V."
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CONCLUSION
In conclusion, CAD-RADS has been developed based on scientific data, expert guidance from leaders in cardiac imaging and a multi-disciplinary effort involving radiology and cardiology societies (Society 
